Albany Molecular Research Inc (NASDAQ:AMRI)

17.19
Delayed Data
As of Mar 03
 +0.14 / +0.82%
Today’s Change
13.73
Today|||52-Week Range
23.95
+5.59%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close17.05
Today’s open17.08
Day’s range17.08 - 17.39
Volume687,500
Average volume (3 months)539,727
Market cap$556.3M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+30.16%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.92
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc-0.09-2.91%
FLXNFlexion Therapeutics...+0.43+1.89%
LXRXLexicon Pharmaceutic...+0.03+2.93%
ARWRArrowhead Research C...-0.11-1.50%
Data as of 03/03/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
Senior VP
Felicia Ladin
Corporate headquarters
Albany, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account